查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1871921

全球治疗性虚拟实境市场：预测至 2032 年—按组件、技术、应用、最终用户和地区分類的分析

Virtual Reality in Therapy Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software and Services), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球治疗性虚拟实境市场价值将达到 32 亿美元，到 2032 年将达到 83 亿美元，在预测期内的复合年增长率为 14.6%。

治疗性虚拟实境（VR）是指利用身临其境型电脑生成环境来治疗心理、神经和生理健康问题。患者可以参与受控的互动式模拟，这些模拟旨在促进情绪调节、认知復健、疼痛管理和运动功能恢復。透过在安全、可自订的环境中复製真实世界场景，VR疗法可以帮助患者克服恐惧、练习应对策略并参与指导下的復健训练。这项技术融合了临床心理学、神经科学和数位创新，提供更具沉浸感和可衡量的治疗体验。最终，它能够提高患者参与度、治疗依从性以及心理健康和復健领域的整体復健效果。

人们对心理健康的认识不断提高

全球对焦虑、创伤后压力症候群（PTSD）和忧郁症心理健康问题的日益关注，正在推动虚拟实境（VR）治疗技术的应用。随着社会努力消除对心理健康治疗的偏见，医疗服务提供者正转向身临其境型VR解决方案，以增强患者参与度并改善治疗效果。各国政府和组织正在投资建立数位心理健康基础设施，支持创新治疗工具，从而提高治疗的可近性和可负担性。人们对心理健康护理的日益接受以及对整体健康的关注，正显着推动全球对基于VR的治疗性介入的需求。

高成本设备

虚拟实境硬体、软体和技术整合的高成本是限制市场发展的主要阻碍因素。先进的VR头戴装置、动作感测器和专用程序需要大量投资，这使得小规模医疗机构和个人执业者难以负担。此外，维护和定期软体更新也增加了营运成本。虚拟实境治疗的保险覆盖范围有限也阻碍了其广泛应用。这些经济障碍正在减缓市场渗透，尤其是在发展中地区。

技术进步

虚拟实境硬体、人工智慧和运动追踪技术的持续进步为市场扩张创造了强劲机会。更高的视觉保真度、更佳的触觉回馈和更低的延迟，使虚拟实境体验更具沉浸感，临床疗效也更显着。人工智慧和数据分析的融合，实现了对每位患者康復进展的即时监测和个人化治疗方案的发展。此外，价格亲民且便携的虚拟实境设备的开发，也推动了其在医院的广泛应用。这些创新正迅速推动虚拟实境成为全球主流治疗工具。

资料隐私问题

资料隐私和安全问题对治疗性虚拟实境市场构成日益严重的威胁。随着虚拟实境系统收集敏感的患者数据，例如行为反应、生物识别和情绪回馈，资料外洩和未授权存取的风险也随之增加。遵守诸如 HIPAA 和 GDPR 等医疗保健隐私法规，进一步增加了实施的复杂性。网路安全措施不足会削弱病患的信任，并延缓科技的普及。企业必须投资先进的加密技术和安全的资料管理系统，以确保资料保密性，并建立病患对基于虚拟实境的治疗解决方案的信任。

新冠疫情的影响：

新冠疫情显着加速了虚拟实境技术在治疗领域的应用，提升了远端医疗和数位心理健康解决方案的重要性。由于面对面治疗受限，虚拟实境技术已成为提供身临其境型和互动式治疗体验的关键工具。医疗服务提供者利用虚拟实境技术帮助隔离患者应对焦虑、孤独和復原挑战。疫情也促进了远距治疗技术的创新和投资，使其更易于取得且价格更亲民。

预计在预测期内，恐惧症治疗领域将占据最大的市场规模。

预计在预测期内，恐惧症治疗领域将占据最大的市场份额。这主要归功于虚拟实境（VR）在暴露疗法中的有效性。在虚拟环境中，患者可以在专家的指导下，在安全可控的环境中面对恐惧，例如恐惧症高症、飞行恐惧症和社交恐惧症。这项技术能够在避免现实世界风险的前提下，带来可衡量的进步，进而改善治疗效果。越来越多的临床证据支持基于VR的恐惧症治疗，加上人们对心理健康意识的提高以及身临其境型技术的普及，预计未来几年该领域的领先地位将进一步巩固。

预计在预测期内，研究机构板块的复合年增长率将最高。

预计在预测期内，研究机构板块将实现最高成长率，因为临床研究中心正在增加对虚拟实境（VR）技术的投资，用于认知行为疗法、復健和神经疗法研究。 VR与神经科学和心理分析的融合，有助于更好地理解大脑反应和治疗效果。政府机构的资助以及与科技公司的合作，正在加速基于VR的临床应用领域的创新。不断完善的研究验证将进一步推动虚拟实境解决方案在全球医疗保健领域的商业化应用。

占比最大的地区：

由于医疗数位化进程的快速发展、政府的大力主导以及人们对心理健康问题的日益关注，亚太地区预计将在预测期内保持最大的市场份额。中国、日本、韩国和印度等国家正大力投资先进的医疗技术和远端医疗平台。该地区不断完善的医疗基础设施、大规模的患者群体以及不断增长的可支配收入都在支撑市场成长。此外，本地虚拟实境（VR）开发商的日益增多以及研究合作的不断加强，也进一步巩固了亚太地区在虚拟实境治疗行业的领先地位。

预计年复合成长率最高的地区：

在预测期内，由于强劲的技术创新和数位健康解决方案的早期应用，北美预计将实现最高的复合年增长率。美国和加拿大拥有强大的虚拟实境（VR）开发商、医疗服务提供者和研究机构生态系统，致力于推动身临其境型疗法的发展。人们对心理健康的日益关注以及政府对数位疗法的支持正在推动该地区的成长。此外，VR公司与医疗机构之间的合作不断增强，提高了临床疗效的可及性和检验，巩固了北美在该市场的主导地位。

免费客製化服务：

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
  • 分析材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球治疗性虚拟实境市场（按组件划分）

  • 硬体
  • 软体
  • 服务

6. 全球治疗性虚拟实境市场（依技术划分）

  • 非身临其境型
  • 半身临其境型
  • 完全身临其境型

7. 全球治疗性虚拟实境市场（按应用划分）

  • 物理治疗
  • 恐惧症治疗
  • 认知疗法
  • 创伤后压力症候群治疗
  • 心理治疗
  • 中风復健
  • 疼痛管理
  • 其他用途

8. 全球治疗性虚拟实境市场（依最终用户划分）

  • 医院和诊所
  • 精神健康机构
  • 復健中心
  • 居家医疗
  • 研究所
  • 其他最终用户

9. 全球治疗性虚拟实境市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十一章 公司简介

  • AppliedVR
  • Oxford VR
  • XRHealth
  • Limbix
  • Psious
  • BehaVR
  • MyndVR
  • Vivid Vision
  • DeepStream VR
  • Neuro Rehab VR
  • Tripp
  • SimX
  • Rendever
  • MindMaze
  • FundamentalVR
Product Code: SMRC32291

According to Stratistics MRC, the Global Virtual Reality in Therapy Market is accounted for $3.2 billion in 2025 and is expected to reach $8.3 billion by 2032 growing at a CAGR of 14.6% during the forecast period. Virtual Reality in Therapy refers to the use of immersive, computer-generated environments to treat psychological, neurological, and physical health conditions. It allows patients to engage in controlled, interactive simulations designed to promote emotional regulation, cognitive rehabilitation, pain management, and motor recovery. By replicating real-world scenarios in a safe, customizable setting, VR therapy helps patients confront fears, practice coping mechanisms, or perform guided rehabilitation exercises. This technology bridges clinical psychology, neuroscience, and digital innovation, offering more engaging and measurable therapeutic experiences. Ultimately, it enhances patient motivation, treatment adherence, and overall recovery outcomes across mental health and rehabilitation disciplines.

Market Dynamics:

Driver:

Rising Mental Health Awareness

The growing global awareness of mental health issues such as anxiety, PTSD, and depression is driving the adoption of virtual reality in therapy. As societies destigmatize mental health treatment, healthcare providers are turning to immersive VR solutions to enhance patient engagement and therapeutic outcomes. Governments and organizations are investing in digital mental health infrastructure, supporting innovative therapy tools that improve accessibility and affordability. This rising acceptance of psychological care and focus on holistic wellness significantly boost the demand for VR-based therapeutic interventions worldwide.

Restraint:

High Equipment Costs

The high cost of virtual reality hardware, software, and technical integration acts as a major restraint for the market. Advanced VR headsets, motion sensors, and specialized programs require significant investment, making them less accessible for smaller healthcare providers or individual practitioners. Additionally, maintenance and regular software updates increase operational expenses. Limited insurance coverage for VR-based therapies further discourages widespread adoption. These financial barriers, particularly in developing regions, slow down market penetration.

Opportunity:

Advancements in technology

Continuous advancements in virtual reality hardware, artificial intelligence, and motion tracking technologies are creating strong opportunities for market expansion. Enhanced visual fidelity, improved haptic feedback, and reduced latency are making VR experiences more immersive and clinically effective. Integration with AI and data analytics enables real-time monitoring and personalized therapy plans tailored to individual progress. Moreover, the development of affordable and portable VR devices is increasing accessibility across hospitals. These innovations are accelerating VR's adoption as a mainstream therapeutic tool globally.

Threat:

Data Privacy Concerns

Data privacy and security concerns pose a growing threat to the virtual reality in therapy market. As VR systems collect sensitive patient data-such as behavioral responses, biometrics, and emotional feedback-risks of data breaches or unauthorized access rise. Compliance with healthcare privacy regulations like HIPAA and GDPR adds complexity to implementation. Inadequate cybersecurity measures can undermine patient trust and delay adoption. Companies must invest in advanced encryption and secure data management systems to ensure confidentiality and build confidence in VR-based therapeutic solutions.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption of virtual reality in therapy as remote healthcare and digital mental health solutions gained prominence. With in-person therapy sessions restricted, VR emerged as a vital tool for delivering immersive, interactive treatment experiences. Healthcare providers leveraged VR to manage anxiety, loneliness, and rehabilitation challenges in isolated patients. The pandemic also spurred innovation and investment in teletherapy technologies, expanding accessibility and affordability.

The phobia treatment segment is expected to be the largest during the forecast period

The phobia treatment segment is expected to account for the largest market share during the forecast period, due to effectiveness of VR in exposure therapy. Virtual environments allow patients to confront fears-such as heights, flying, or social situations-in a safe and controlled setting under professional supervision. This method offers measurable progress without real-world risks, improving therapy outcomes. Growing clinical evidence supporting VR-based phobia treatment, coupled with increasing mental health awareness and accessibility to immersive technology, fuels the segment's dominance in the coming years.

The research institutes segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the research institutes segment is predicted to witness the highest growth rate as clinical research centers are increasingly investing in VR technology to study cognitive behavior, rehabilitation, and neurotherapy. The integration of VR with neuroscience and psychology research enables better understanding of brain responses and therapeutic efficacy. Funding from government bodies and collaborations with tech companies are accelerating innovation in VR-based clinical applications. As research validation grows, it drives broader commercialization of virtual reality solutions across healthcare sectors globally.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid healthcare digitalization, strong government initiatives, and increasing awareness of mental health issues. Countries like China, Japan, South Korea, and India are investing heavily in advanced medical technologies and telehealth platforms. The region's expanding healthcare infrastructure, large patient base, and rising disposable incomes support market growth. Additionally, the growing presence of local VR developers and research collaborations further strengthen Asia Pacific's dominance in the virtual reality therapy industry.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong technological innovation and early adoption of digital health solutions. The United States and Canada have a robust ecosystem of VR developers, healthcare providers, and research institutions working to advance immersive therapies. Rising mental health concerns and government support for digital therapeutics propel regional growth. Furthermore, collaborations between VR companies and healthcare organizations continue to enhance accessibility and clinical validation, solidifying North America's leadership in this market.

Key players in the market

Some of the key players in Virtual Reality in Therapy Market include AppliedVR, Oxford VR, XRHealth, Limbix, Psious, BehaVR, MyndVR, Vivid Vision, DeepStream VR, Neuro Rehab VR, Tripp, SimX, Rendever, MindMaze, and FundamentalVR.

Key Developments:

In September 2025, Relief Therapeutics Holding SA and NeuroX Group SA, the successor to MindMaze Group SA, have signed a definitive agreement to merge, creating a publicly-listed, AI-driven neurotherapeutics company to be renamed MindMaze Therapeutics Holding SA.

In June 2022, MindMaze has partnered with University of Auckland to launch their "ESPRESSo" Phase 2 trial, using an immersive neuro-animation system called MindPod within two weeks of stroke onset aimed at boosting upper-limb recovery.

Components Covered:

  • Hardware
  • Software
  • Services

Technologies Covered:

  • Non-immersive
  • Semi-immersive
  • Fully immersive

Applications Covered:

  • Physical Therapy
  • Phobia Treatment
  • Cognitive Therapy
  • PTSD Treatment
  • Psychological Therapy
  • Stroke Rehabilitation
  • Pain Management
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Mental Health Institutions
  • Rehabilitation Centers
  • Homecare Settings
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Virtual Reality in Therapy Market, By Component

  • 5.1 Introduction
  • 5.2 Hardware
  • 5.3 Software
  • 5.4 Services

6 Global Virtual Reality in Therapy Market, By Technology

  • 6.1 Introduction
  • 6.2 Non-immersive
  • 6.3 Semi-immersive
  • 6.4 Fully immersive

7 Global Virtual Reality in Therapy Market, By Application

  • 7.1 Introduction
  • 7.2 Physical Therapy
  • 7.3 Phobia Treatment
  • 7.4 Cognitive Therapy
  • 7.5 PTSD Treatment
  • 7.6 Psychological Therapy
  • 7.7 Stroke Rehabilitation
  • 7.8 Pain Management
  • 7.9 Other Applications

8 Global Virtual Reality in Therapy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Mental Health Institutions
  • 8.4 Rehabilitation Centers
  • 8.5 Homecare Settings
  • 8.6 Research Institutes
  • 8.7 Other End Users

9 Global Virtual Reality in Therapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 AppliedVR
  • 11.2 Oxford VR
  • 11.3 XRHealth
  • 11.4 Limbix
  • 11.5 Psious
  • 11.6 BehaVR
  • 11.7 MyndVR
  • 11.8 Vivid Vision
  • 11.9 DeepStream VR
  • 11.10 Neuro Rehab VR
  • 11.11 Tripp
  • 11.12 SimX
  • 11.13 Rendever
  • 11.14 MindMaze
  • 11.15 FundamentalVR

List of Tables

  • Table 1 Global Virtual Reality in Therapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Virtual Reality in Therapy Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Virtual Reality in Therapy Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 4 Global Virtual Reality in Therapy Market Outlook, By Software (2024-2032) ($MN)
  • Table 5 Global Virtual Reality in Therapy Market Outlook, By Services (2024-2032) ($MN)
  • Table 6 Global Virtual Reality in Therapy Market Outlook, By Technology (2024-2032) ($MN)
  • Table 7 Global Virtual Reality in Therapy Market Outlook, By Non-immersive (2024-2032) ($MN)
  • Table 8 Global Virtual Reality in Therapy Market Outlook, By Semi-immersive (2024-2032) ($MN)
  • Table 9 Global Virtual Reality in Therapy Market Outlook, By Fully immersive (2024-2032) ($MN)
  • Table 10 Global Virtual Reality in Therapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 11 Global Virtual Reality in Therapy Market Outlook, By Physical Therapy (2024-2032) ($MN)
  • Table 12 Global Virtual Reality in Therapy Market Outlook, By Phobia Treatment (2024-2032) ($MN)
  • Table 13 Global Virtual Reality in Therapy Market Outlook, By Cognitive Therapy (2024-2032) ($MN)
  • Table 14 Global Virtual Reality in Therapy Market Outlook, By PTSD Treatment (2024-2032) ($MN)
  • Table 15 Global Virtual Reality in Therapy Market Outlook, By Psychological Therapy (2024-2032) ($MN)
  • Table 16 Global Virtual Reality in Therapy Market Outlook, By Stroke Rehabilitation (2024-2032) ($MN)
  • Table 17 Global Virtual Reality in Therapy Market Outlook, By Pain Management (2024-2032) ($MN)
  • Table 18 Global Virtual Reality in Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 19 Global Virtual Reality in Therapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 20 Global Virtual Reality in Therapy Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 21 Global Virtual Reality in Therapy Market Outlook, By Mental Health Institutions (2024-2032) ($MN)
  • Table 22 Global Virtual Reality in Therapy Market Outlook, By Rehabilitation Centers (2024-2032) ($MN)
  • Table 23 Global Virtual Reality in Therapy Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 24 Global Virtual Reality in Therapy Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 25 Global Virtual Reality in Therapy Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.